Physician profile
Steven E Szames
NPI 1063505238
$7,815.18
in general payments reported to CMS, 2019-2025
11 companies · $528 in 2025
The $528 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869 · 2020: $575 · 2021: $1,451 · 2022: $1,983 · 2023: $1,009 · 2024: $1,399 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,936.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,091.10 | 2019-2024 | Citrefix, Prostep, Hoffmann |
| Sanara Medtech INC. | $313.10 | 2024-2025 | Celleraterx, Celleraterx |
| Inari Medical, INC. | $218.70 | 2022 | |
| Wright Medical Technology, INC. | $216.01 | 2019 | |
| Paragon 28, INC. | $195.63 | 2022 | |
| Smith+Nephew, INC. | $169.41 | 2022-2025 | Grafix Pl, Stravix Pl, Stravix |
| Bone Support INC. | $141.77 | 2025 | Ceramentbone Void Filler, Cerament G |
| Abbott Laboratories | $133.89 | 2019 | |
| Orthofix Medical, INC. | $129.63 | 2023 | Tl-Hex Truelok Hexapod System, Truelok System |
| Kerecis Limited | $116.45 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $89.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Szames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.